Cite
HARVARD Citation
Lotan, Y. et al. (2018). Modelling cost‐effectiveness of a biomarker‐based approach to neoadjuvant chemotherapy for muscle‐invasive bladder cancer. BJU international. pp. 434-440. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lotan, Y. et al. (2018). Modelling cost‐effectiveness of a biomarker‐based approach to neoadjuvant chemotherapy for muscle‐invasive bladder cancer. BJU international. pp. 434-440. [Online].